Transcripts Sensorion

Stocks

ALSEN

FR0012596468

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:55:00 2026-09-02 EDT			5-day change	1st Jan Change
0.2570 ^EUR	-3.38%		-7.55%	-23.74%

06-11	Sensorion continues its decline despite Stifel's positive outlook
06-10	Sensorion Achieves Key Regulatory Milestones for Sens-601 for Gjb2-Related Hearing Loss and Selects Program as Lead Gene Therapy Candidate	CI

Transcripts

25-01-14

Sensorion SA Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 04:30 PM

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!